Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2026-04-23 @ 9:25 PM
Study NCT ID:
NCT02309294
Status:
COMPLETED
Last Update Posted:
2016-10-12
First Post:
2014-12-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
14-Day Cumulative Irritation Patch Test in Subjects With Normal Skin
Sponsor:
Church & Dwight Company, Inc.
Organization:
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2016-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this study is to determine the ability of the study material to cause irritation to the skin of humans under controlled patch test conditions. Substances that come into contact with human skin need to be evaluated for their propensity to irritate and/or sensitize. This testing is a modified primary irritancy patch test that can detect weak irritants that require multiple applications to cause a skin reaction.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: